Browsing Tag
Investigational New Drug
2 posts
Biotech breakthrough in PTSD? Silo Pharma and Allucent move toward FDA IND filing for SPC-15 therapy
Silo Pharma partners with Allucent to advance its planned FDA IND for intranasal PTSD therapeutic SPC-15. Find out how this collaboration could shape future mental health treatment.
X-Rx announces FDA acceptance of IND for X-165, a potential treatment for Idiopathic Pulmonary Fibrosis
US-based biotech company X-Rx has received a major boost in its quest to develop new treatments for Idiopathic…